Skip to main content
. 2022 Mar 14;28(4):743–751. doi: 10.1038/s41591-022-01720-7

Extended Data Fig. 3. Immunophenotype of KMT2A-rearranged infant B-ALL.

Extended Data Fig. 3

Left: Histograms showing surface antigen expression in a representative primary KMT2A-rearranged infant B-ALL sample relative to negative control. Right: Scatterplot showing percentage of cells in each sample expressing ELP-characteristic antigens > negative control (n = 2 xenograft, n = 4 primary KMT2A-rearranged infant B-ALL). Line= mean; 82% CD7+, 93% CD127+ and 82% FLT3+).